AAAAAA
Results:
1-15
|
Results: 15
Authors:
WASHINGTON CB
DURAN GE
MAN MC
SIKIC BI
BLASCHKE TF
Citation: Cb. Washington et al., INTERACTION OF ANTI-HIV PROTEASE INHIBITORS WITH THE MULTIDRUG TRANSPORTER P-GLYCOPROTEIN (P-GP) IN HUMAN CULTURED-CELLS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(3), 1998, pp. 203-209
Authors:
CHEN G
DURAN GE
STEGER KA
LACAYO NJ
JAFFREZOU JP
DUMONTET C
SIKIC BI
Citation: G. Chen et al., MULTIDRUG-RESISTANT HUMAN SARCOMA-CELLS WITH A MUTANT P-GLYCOPROTEIN,ALTERED PHENOTYPE, AND RESISTANCE TO CYCLOSPORINES, The Journal of biological chemistry, 272(9), 1997, pp. 5974-5982
Authors:
WASHINGTON CB
DURAN GE
SIKIC BI
BLASCHKE TF
Citation: Cb. Washington et al., SAQUINAVIR IS A HIGH-AFFINITY SUBSTRATE FOR THE MULTIDRUG TRANSPORTER, P-GLYCOPROTEIN, Clinical pharmacology and therapeutics, 61(2), 1997, p.
Authors:
KUHL JS
KRAJEWSKI S
DURAN GE
REED JC
SIKIC BI
Citation: Js. Kuhl et al., SPONTANEOUS OVEREXPRESSION OF THE LONG FORM OF THE BCL-X PROTEIN IN AHIGHLY RESISTANT P388 LEUKEMIA, British Journal of Cancer, 75(2), 1997, pp. 268-274
Authors:
DUMONTET C
DURAN GE
STEGER KA
MURPHY GL
SUSSMAN HH
SIKIC BI
Citation: C. Dumontet et al., DIFFERENTIAL EXPRESSION OF TUBULIN ISOTYPES DURING THE CELL-CYCLE, Cell motility and the cytoskeleton, 35(1), 1996, pp. 49-58
Authors:
DURAN GE
LAU DHM
LEWIS AD
KUHL JS
BAMMLER TK
SIKIC BI
Citation: Ge. Duran et al., DIFFERENTIAL SINGLE-STRAND VERSUS DOUBLE-STRAND DNA BREAKAGE PRODUCEDBY DOXORUBICIN AND ITS MORPHOLINYL ANALOGS, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 210-216
Authors:
DUMONTET C
DURAN GE
STEGER KA
BEKETICORESKOVIC L
SIKIC BI
Citation: C. Dumontet et al., RESISTANCE MECHANISMS IN HUMAN SARCOMA MUTANTS DERIVED BY SINGLE-STEPEXPOSURE TO PACLITAXEL (TAXOL), Cancer research, 56(5), 1996, pp. 1091-1097
Authors:
BEKETICORESKOVIC L
DURAN GE
CHEN G
DUMONTET C
SIKIC BI
Citation: L. Beketicoreskovic et al., DECREASED MUTATION-RATE FOR CELLULAR-RESISTANCE TO DOXORUBICIN AND SUPPRESSION OF MDR1 GENE ACTIVATION BY THE CYCLOSPORINE PSC-833, Journal of the National Cancer Institute, 87(21), 1995, pp. 1593-1602
Authors:
JAFFREZOU JP
CHEN G
DURAN GE
MULLER C
BORDIER C
LAURENT G
SIKIC BI
LEVADE T
Citation: Jp. Jaffrezou et al., INHIBITION OF LYSOSOMAL ACID SPHINGOMYELINASE BY AGENTS WHICH REVERSEMULTIDRUG-RESISTANCE, Biochimica et biophysica acta. Molecular cell research, 1266(1), 1995, pp. 1-8
Authors:
JAFFREZOU JP
CHEN G
DURAN GE
KUHL JS
SIKIC BI
Citation: Jp. Jaffrezou et al., MUTATION-RATES AND MECHANISMS OF RESISTANCE TO ETOPOSIDE DETERMINED FROM FLUCTUATION ANALYSIS, Journal of the National Cancer Institute, 86(15), 1994, pp. 1152-1158
Authors:
LAU DHM
DURAN GE
SIKIC BI
Citation: Dhm. Lau et al., ANALYSIS OF INTRACELLULAR RETENTION OF MORPHOLINYL ANTHRACYCLINES IN MULTIDRUG-RESISTANT CANCER-CELLS BY INTERACTIVE LASER CYTOMETRY, International journal of oncology, 5(6), 1994, pp. 1273-1277
Authors:
DONG YJ
CHEN G
DURAN GE
KOUYAMA K
CHAO AC
SIKIC BI
GOLLAPUDI SV
GUPTA S
GARDNER P
Citation: Yj. Dong et al., VOLUME-ACTIVATED CHLORIDE CURRENT IS NOT RELATED TO P-GLYCOPROTEIN OVEREXPRESSION, Cancer research, 54(19), 1994, pp. 5029-5032
Authors:
CHEN G
JAFFREZOU JP
FLEMING WH
DURAN GE
SIKIC BI
Citation: G. Chen et al., PREVALENCE OF MULTIDRUG-RESISTANCE RELATED TO ACTIVATION OF THE MDR1 GENE IN HUMAN SARCOMA MUTANTS DERIVED BY SINGLE-STEP DOXORUBICIN SELECTION, Cancer research, 54(18), 1994, pp. 4980-4987
Authors:
LAU DHM
DURAN GE
LEWIS AD
SIKIC BI
Citation: Dhm. Lau et al., METABOLIC CONVERSION OF METHOXYMORPHOLINYL DOXORUBICIN - FROM A DNA STRAND BREAKER TO A DNA CROSS-LINKER, British Journal of Cancer, 70(1), 1994, pp. 79-84
Authors:
KUHL JS
DURAN GE
CHAO NJ
SIKIC BI
Citation: Js. Kuhl et al., EFFECTS OF THE METHOXYMORPHOLINO DERIVATIVE OF DOXORUBICIN AND ITS BIOACTIVATED FORM VERSUS DOXORUBICIN ON HUMAN LEUKEMIA AND LYMPHOMA CELL-LINES AND NORMAL BONE-MARROW, Cancer chemotherapy and pharmacology, 33(1), 1993, pp. 10-16
Risultati:
1-15
|